5.
复发组与未复发患者基线资料比较
Comparison of baseline data between the recurrence and non-recurrence groups
| Ariable | Re (n=16) | NRe (n=33) | F/χ2 | P |
| Age (year) | 63.50±9.89 | 69.55±12.47 | 2.87 | |
| Male (n, %) | 11 (68.75) | 20 (60.61) | 0.31 | |
| Smoking (n, %) | 0 (0) | 7(21.21) | - | |
| Hypertension (n, %) | 8 (50.00) | 17 (51.52) | 0.1 | |
| Diabetes mellitus (n, %) | 0 (0) | 7 (21.21) | - | |
| Cerebral infarction (n, %) | 4 (25) | 9 (27.27) | - | |
| Anticoagulant (n, %) | 16 (100) | 33 (100) | - | |
| Amiodarone (n, %) | 16 (100) | 33 (100) | - | |
| RBC/ (×1012/L) | 4.40±1.21 | 4.49±0.76 | 0.94 | P>0.05 |
| WBC/ (×109/L) | 6.54±2.03 | 6.26±2.00 | 0.22 | |
| PLT/ (×109/L) | 190.06±29.56 | 208.33±58.62 | 1.37 | |
| BNP (pg/mL) | 70.05±39.11 | 55.56±33.92 | 1.78 | |
| LVEF (%) | 58.25±6.02 | 55.36±7.21 | 0.81 | |
| ALT (U/L) | 22.50±9.85 | 22.24±8.75 | 0.01 | |
| AST (U/L) | 25.50±9.40 | 28.24±14.48 | 0.47 | |
| SCR (μmol/L) | 68.25±17.73 | 68.73±19.56 | 0.01 | |
| LDL (mmol/L) | 2.27±0.82 | 2.48±0.83 | 0.69 |